Finally, and most remarkably, we show that G12V mutants without ACSS2 are unable to form tumors in mice, whereas G12D mutants were still able to form and growth tumors despite ACSS2 KO, while ACSS2 inhibition in vivo results in a significant reduction in tumor growth combined with MEK inhibition. The gene discussed is MAP2K7; the disease is neoplasm.